Stories & Highlights August 13, 2025
PACT suppresses PKR activation through dsRNA binding and dimerization, and is a therapeutic target for triple-negative breast cancer Triple-negative breast cancer (TNBC) is the deadliest breast cancer subtype and among the most difficult cancers to treat. A team of Purdue…
Read MoreStories & Highlights July 3, 2025
The Purdue Institute for Cancer Research (PICR) has been honored with a silver award in the 2025 Circle of Excellence Awards from the Council for Advancement and Support of Education (CASE), recognizing outstanding achievement in educational advancement worldwide. The award, presented in…
Read MoreCancer Research Community Stories Stories & Highlights April 24, 2025
Purdue-invented therapy tested in IU clinical trial offers new hope for U.S. Army veteran Fierce athletic rivals Purdue and Indiana universities have joined forces to claim a victory that far transcends sports. Together, these Big Ten universities have propelled Pluvicto™ —…
Read More